Cargando…

Super-enhancer-driven lncRNA LIMD1-AS1 activated by CDK7 promotes glioma progression

Long non-coding RNAs (lncRNAs) are tissue-specific expression patterns and dysregulated in cancer. How they are regulated still needs to be determined. We aimed to investigate the functions of glioma-specific lncRNA LIMD1-AS1 activated by super-enhancer (SE) and identify the potential mechanisms. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Zhigang, Tian, Dasheng, Chen, Xueran, Cheng, Meng, Xie, Han, Zhao, JiaJia, Liu, Jun, Fang, Zhiyou, Zhao, Bing, Bian, Erbao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310775/ https://www.ncbi.nlm.nih.gov/pubmed/37385987 http://dx.doi.org/10.1038/s41419-023-05892-z

Ejemplares similares

Integrative analysis of a novel super-enhancer-associated lncRNA prognostic signature and identifying LINC00945 in aggravating glioma progression
por: Yang, Zhihao, et al.
Publicado: (2023)

Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with Myc
por: Bian, Erbao, et al.
Publicado: (2021)

A Novel Defined Endoplasmic Reticulum Stress-Related lncRNA Signature for Prognosis Prediction and Immune Therapy in Glioma
por: Zheng, Yinfei, et al.
Publicado: (2022)

A central role for MeCP2 in the epigenetic repression of miR-200c during epithelial-to-mesenchymal transition of glioma
por: Bian, Erbao, et al.
Publicado: (2019)

A Signature of Nine lncRNA Methylated Genes Predicts Survival in Patients With Glioma
por: Cheng, Meng, et al.
Publicado: (2021)

The super-enhancer-driven lncRNA LINC00880 acts as a scaffold between CDK1 and PRDX1 to sustain the malignance of lung adenocarcinoma
por: Feng, Yipeng, et al.
Publicado: (2023)

LIMD1‐AS1 suppressed non‐small cell lung cancer progression through stabilizing LIMD1 mRNA via hnRNP U
por: Pan, Jianyuan, et al.
Publicado: (2020)

LncRNA PCGEM1 contributes to malignant behaviors of glioma by regulating miR-539-5p/CDK6 axis
por: Liu, Shu-Li, et al.
Publicado: (2021)

Differential Expression Profile of lncRNA in Glioma Cells and the Effect of lncRNA NKX3-1 on Glioma Cells Through Fem1b/SPDEF Pathway
por: Cai, Yang, et al.
Publicado: (2021)

Specific Glioma Prognostic Subtype Distinctions Based on DNA Methylation Patterns
por: Chen, Xueran, et al.
Publicado: (2019)

LncRNA DCST1-AS1 Sponges miR-107 to Upregulate CDK6 in Cervical Squamous Cell Carcinoma
por: Zhou, Zhigang, et al.
Publicado: (2020)

LIMD1 is a survival prognostic marker of gastric cancer and hinders tumor progression by suppressing activation of YAP1
por: Zhang, Di, et al.
Publicado: (2018)

PU.1 is a major transcriptional activator of the tumour suppressor gene LIMD1
por: Foxler, Daniel E., et al.
Publicado: (2011)

AJUBA and WTIP can compete with LIMD1 for junctional localization and LATS regulation
por: Kirichenko, Elmira, et al.
Publicado: (2022)

Upregulation of Biomarker Limd1 Was Correlated with Immune Infiltration in Doxorubicin-Related Cardiotoxicity
por: Zhang, Rui, et al.
Publicado: (2023)

Prognostic potential of lncRNA RHPN1-AS1 in glioma
por: Wu, Yong, et al.
Publicado: (2020)

EGR1 modulated LncRNA HNF1A-AS1 drives glioblastoma progression via miR-22-3p/ENO1 axis
por: Ma, Chunchun, et al.
Publicado: (2021)

LncRNA HSP90AA1-IT1 promotes gliomas by targeting miR-885-5p-CDK2 pathway
por: Gao, Taihong, et al.
Publicado: (2017)

LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas
por: Wang, Wen, et al.
Publicado: (2016)

SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation
por: Landry, Natalie M., et al.
Publicado: (2021)

Targeted therapy for LIMD1-deficient non-small cell lung cancer subtypes
por: Davidson, Kathryn, et al.
Publicado: (2021)

LncRNA FOXD1‐AS1 acts as a potential oncogenic biomarker in glioma
por: Gao, Yuan‐Feng, et al.
Publicado: (2019)

A HIF–LIMD1 negative feedback mechanism mitigates the pro‐tumorigenic effects of hypoxia
por: Foxler, Daniel E, et al.
Publicado: (2018)

Overexpression of lncRNA PTENP1 suppresses glioma cell proliferation and metastasis in vitro
por: Hu, Su, et al.
Publicado: (2018)

LncRNA NCK1-AS1 promotes proliferation and induces cell cycle progression by crosstalk NCK1-AS1/miR-6857/CDK1 pathway
por: Li, Haiyu, et al.
Publicado: (2018)

HSF1 Stimulates Glutamine Transport by Super-Enhancer-Driven lncRNA LINC00857 in Colorectal Cancer
por: Shen, Qi, et al.
Publicado: (2022)

LIMD1 Increases the Sensitivity of Lung Adenocarcinoma Cells to Cisplatin via the GADD45α/p38 MAPK Signaling Pathway
por: Zeng, Xiaofei, et al.
Publicado: (2020)

The CDK1-Related lncRNA and CXCL8 Mediated Immune Resistance in Lung Adenocarcinoma
por: Xue, Jinmin, et al.
Publicado: (2022)

Super-enhancers complexes zoom in transcription in cancer
por: Wang, MengTing, et al.
Publicado: (2023)

Identification of an endoplasmic reticulum stress-related signature associated with clinical prognosis and immune therapy in glioma
por: Li, Lianxin, et al.
Publicado: (2022)

miR-550a-5p Functions as a Tumor Promoter by Targeting LIMD1 in Lung Adenocarcinoma
por: Guo, Zi-Zhang, et al.
Publicado: (2020)

Knockdown of lncRNA HOXD-AS2 Improves the Prognosis of Glioma Patients by Inhibiting the Proliferation and Migration of Glioma Cells
por: Chen, Feng, et al.
Publicado: (2022)

LncRNA NEAT1 facilitates glioma progression via stabilizing PGK1
por: Liang, Jingshan, et al.
Publicado: (2022)

LncRNA PANTR1 is Associated with Poor Prognostic and Suppresses Apoptosis in Glioma
por: Shi, Fei, et al.
Publicado: (2023)

lncRNA TRHDE-AS1 Correlated with Genomic Landscape and Clinical Outcome in Glioma
por: Xie, Jinxuan, et al.
Publicado: (2023)

Development of an Immune-Related LncRNA Prognostic Signature for Glioma
por: Cao, Yudong, et al.
Publicado: (2021)

DHHC protein family targets different subsets of glioma stem cells in specific niches
por: Chen, Xueran, et al.
Publicado: (2019)

Super enhancer‐LncRNA SENCR promoted cisplatin resistance and growth of NSCLC through upregulating FLI1
por: Shen, Qiang, et al.
Publicado: (2022)

METTL3‐stabilized super enhancers‐lncRNA SUCLG2‐AS1 mediates the formation of a long‐range chromatin loop between enhancers and promoters of SOX2 in metastasis and radiosensitivity of nasopharyngeal carcinoma
por: Hu, Xinyu, et al.
Publicado: (2023)

LncRNA SNHG12 regulates the radiosensitivity of cervical cancer through the miR-148a/CDK1 pathway
por: Wang, Chen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_llnt0j3knv1uimdqjfa398np61